ISRG Q3 deep dive: margin pressure overshadows strong adoption and international growth

Medical technology company Intuitive Surgical (NASDAQ:ISRG) beat Wall Street’s revenue expectations in Q3 2026, with sales up 21.7% year on year to $3.05 billion. Its non-GAAP profit of $3 per share was 13.6% above analysts’ consensus estimates.